July 2021 Question of the Month

Based on the $56k yearly cost, what will be the greatest barrier to launch success for the newly approved Alzheimer’s disease drug Aduhelm™?
Physician willingness to recommend or prescribe: 0%
Cost to plan or CMS: 75%
Cost to patient: 25%
Slow uptake due to potential efficacy issues: 0%